Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Clinical Chemistry

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINCHEM/38.11.2203PMID 1424112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic Efficiency of Troponin T Measurements in Acute Myocardial Infarction

  1991cited by this paper
• Developmental expression of troponin I isoforms in fetal human heart

  1991cited by this paper
• Fast and slow isoforms of troponin I and troponin C. Distribution in normal rabbit muscles and effects of chronic stimulation.

  1990cited by this paper
• Developmental Difference in the Stimulation of Cardiac Myofibrillar Mg2+-ATPase Activity by Calmidazolium

  1990cited by this paper
• Clinical assessment of specific enzyme immunoassay for the human cardiac myosin light chain II (MLC II) with use of monoclonal antibodies.

  1990cited by this paper
• Molecular cloning of human cardiac troponin I using polymerase chain reaction

  1990cited by this paper
• Troponin I switching in the developing heart.

  1989cited by this paper
• Identification and pattern of expression of a developmental isoform of troponin I in chicken and rat cardiac muscle

  1989cited by this paper
• The quantitation of human ventricular myosin light chain 1 in serum after myocardial necrosis and infarction.

  1989cited by this paper
• Cardiac troponin I, isolated from bovine heart, contains two adjacent phosphoserines. A first example of phosphoserine determination by derivatization to S-ethylcysteine.

  1988cited by this paper
• Generation of multiple troponin T isoforms is a common feature of the muscles in various chordate animals.

  1988cited by this paper
• Expression of the troponin complex genes: transcriptional coactivation during myoblast differentiation and independent control in heart and skeletal muscles

  1988cited by this paper
• Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction.

  1987influential reference
• Phosphorylation of troponin I by protein kinase C: mechanism of inhibition by calmodulin and troponin C.

  1987cited by this paper
• Comparison of serum cardiac specific troponin‐I with creatine kinase, creatine kinase‐MB isoenzyme, tropomyosin, myoglobin and C‐reactive protein release in marathon runners: cardiac or skeletal muscle trauma?

  1987cited by this paper
• Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis.

  1986cited by this paper
• Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and streptavidin-agarose.

  1986cited by this paper
• Analytic Review: Blunt Chest Trauma: The Intensivist's Perspective

  1986cited by this paper
• Distribution of isoforms of the myofibrillar proteins in myoid cells of thymus

  1986cited by this paper
• Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (A MILIS Study).

  1985cited by this paper
• How to improve estimates of imprecision.

  1984influential reference
• Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and immobilized streptavidin matrices.

  1984cited by this paper
• Distinction of epitopes by monoclonal antibodies.

  1983cited by this paper
• [20] Distinction of epitopes by monoclonal antibodies

  1983cited by this paper
• Preparation of troponin and its subunits.

  1982cited by this paper
• A multi-rule Shewhart chart for quality control in clinical chemistry.

  1981cited by this paper
• Alterations in cardiac troponin subunits in myocardial infarction.

  1981cited by this paper
• Radioimmunoassay data processing with a small programmable calculator.

  1980cited by this paper
• Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis.

  1980cited by this paper
• The regulation of contractile activity in muscle.

  1979cited by this paper
• Troponin I from human skeletal and cardiac muscles.

  1978cited by this paper
• Comparison of amino acid sequence of troponin I from different striated muscles

  1978cited by this paper
• The localization of the different forms of troponin I in skeletal and cardiac muscle cells.

  1978cited by this paper
• A new method of preparation of troponin I (inhibitory protein) using affinity chromatography. Evidence for three different forms of troponin I in striated muscle

  1974cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper

• High-Sensitivity Troponins and Homocysteine: Combined Biomarkers for Better Prediction of Cardiovascular Events

  2025cites this paper
• Diagnostic Significance of Troponin in Acute Myocardial Infarction

  2024cites this paper
• Electrochemical Detection Strategies for Cardiovascular Disease Biomarkers: Applications in Troponin I and Troponin T Assays

  2024cites this paper
• Surface-enhanced Raman spectroscopy for the characterization of filtrate portions of blood serum samples of myocardial infarction patients using 30 kDa centrifugal filter devices.

  2024cites this paper
• Short-term effects of COVID-19 vaccines on cardiac biomarkers: A comparative study between Pfizer/BioNTech and Sinopharm

  2024cites this paper
• Optical Nanobiosensor-Based Point-of-Care Testing for Cardiovascular Disease Biomarkers.

  2023cites this paper
• Cardiac troponins: Mechanisms of release and role in healthy and diseased subjects

  2022cites this paper
• Multifunctionalized Hydrogel Beads for Label-Free Chemiluminescence Imaging Immunoassay of Acute Myocardial Infarction Biomarkers.

  2022cites this paper
• Cardiac biomarkers: definition, detection, diagnostic use, and efficiency

  2022cites this paper
• Utility of Cardiac Troponins in Patients With Chronic Kidney Disease

  2022cites this paper
• Cardiac troponins – a paradigm for diagnostic biomarker identification and development

  2022influential citation
• ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMB.

  2021cites this paper
• Novel, Highly Sensitive, and Specific Assay to Monitor Acute Myocardial Infarction (AMI) by the Determination of Cardiac Troponin I (cTnI) and Heart-Type Fatty Acid Binding Protein (H-FABP) by a Colloidal Gold-Based Immunochromatographic Test Strip

  2021cites this paper
• Astaxanthin extenuates the inhibition of aldehyde dehydrogenase and Klotho protein expression in cyclophosphamide‐induced acute cardiomyopathic rat model

  2021cites this paper
• Acute Myocardial Infarction associated with Lipid Profile among Patients at Nasiriyah Heart Center

  2021cites this paper
• Comparative Study for Diagnosing Myocardial Damage with Cardiac Enzymes on Myocardial Infarction Patients and Normal Subjects

  2021cites this paper
• Cardiac-Speci c Gene TNNI3 as a Potential Oncogene for Kidney Cancer and Its Involvement in Wnt Signaling Pathway

  2021cites this paper
• Multiplexed chemiluminescence determination of three acute myocardial infarction biomarkers based on microfluidic paper-based immunodevice dual amplified by multifunctionalized gold nanoparticles.

  2020cites this paper
• Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders

  2020cites this paper
• A pilot study on the relation between irisin single-nucleotide polymorphism and risk of myocardial infarction

  2020cites this paper
• Peptide-based antifouling aptasensor for cardiac troponin I detection by surface plasmon resonance applied in medium sized Myocardial Infarction

  2020cites this paper
• Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases

  2020cites this paper
• Gold nanoparticle conjugated magnetic beads for extraction and nucleation based signal amplification in lateral flow assaying

  2020cites this paper
• “Cardiac Troponin I Level in STEMI and Clinical Correlation with Left Ventricular Dysfunction in Bangladeshi Population”

  2020influential citation
• Cardiac Troponin by Point-of-Care Testing: The Once and Future King?

  2020cites this paper
• Electrochemiluminescence Immunosensor Based on Au Nanocluster and Hybridization Chain Reaction Signal Amplification for Ultrasensitive Detection of Cardiac Troponin I.

  2019cites this paper
• Cardiac biomarkers for early detection of cardiac involvement in children with Kawasaki disease: a cross-sectional study

  2019cites this paper
• A graphene oxide/gold nanoparticle-based amplification method for SERS immunoassay of cardiac troponin I.

  2019cites this paper
• The Association of Cardiac Troponin I Level on Admission with the Angiographic Severity of Coronary Artery Disease in Acute STEMI Patients

  2019cites this paper
• Magnetic field assisted preconcentration of biomolecules for lateral flow assaying

  2019cites this paper
• Colloidal gold immunochromatographic strip for Detect AMI biomarker cTnI

  2019cites this paper
• DNA nanotetrahedron-assisted electrochemical aptasensor for cardiac troponin I detection based on the co-catalysis of hybrid nanozyme, natural enzyme and artificial DNAzyme.

  2019influential citation
• A paper microfluidics-based fluorescent lateral flow immunoassay for point-of-care diagnostics of non-communicable diseases.

  2019cites this paper
• Rapid and Sensitive Detection of Cardiac Troponin I for Point-of-Care Tests Based on Red Fluorescent Microspheres

  2018cites this paper
• Ultrasensitive label-free optical microfiber coupler biosensor for detection of cardiac troponin I based on interference turning point effect.

  2018cites this paper
• Analytical validation of cardiac troponin I assays in horses

  2018cites this paper
• Improving the Specificity of Cardiac Biomarkers-The Early Development of Cardiac Troponin I (cTnI) Assays.

  2018cites this paper
• Plasma MiRNA-208b as a Biomarker for Detection of Cardiotoxicity Induced by Acute Cardiovascular Drugs Poisoning

  2018cites this paper
• The trouble with troponin

  2018cites this paper
• Novel biomarkers of cardiovascular disease: Applications in clinical practice

  2018cites this paper
• Studies towards hcTnI Immunodetection Using Electrochemical Approaches Based on Magnetic Microbeads

  2018cites this paper
• La troponina ad alta sensibilità in Italia

  2018cites this paper
• Short-term prognostic value of serum cardiac troponin I levels in neonates with perinatal asphyxia

  2017cites this paper
• Cardiac Troponins: Molecules of Many Surprises.

  2017cites this paper
• High-sensitivity assays for troponin in patients with cardiac disease

  2017cites this paper
• Advances in Cardiac Biomarkers of Acute Coronary Syndrome.

  2017cites this paper
• Transcription factor 21 gene polymorphism in patients with coronary artery disease

  2017cites this paper
• Cardiac troponins: 25 years on the stage and still improving their clinical value

  2017cites this paper
• The Importance of the Troponin Biomarker in Myocardial Infarction

  2016cites this paper
• Flexible Molybdenum Electrodes towards Designing Affinity Based Protein Biosensors

  2016cites this paper
• Cardiac biomarkers in clinical practice of dog and cat - a review.

  2016cites this paper
• Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway.

  2016cites this paper
• Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles

  2016cites this paper
• Pentraxin 3 genotyping in relation to serum levels of pentraxin 3 in patients with acute ST-segment elevation myocardial infarction

  2016cites this paper
• Myocardial Infarction Myoglobin , Creatine-Kinase-MB and Cardiac Troponin-I 60-Minute Ratios Predict Infarct-related Artery Patency After Thrombolysis for Acute Myocardial Infarction Results from the Thrombolysis in Myocardial Infarction Study ( TIMI ) 10 B

  2016cites this paper
• Porous graphene oxide nanostructure as an excellent scaffold for label-free electrochemical biosensor: Detection of cardiac troponin I.

  2016cites this paper
• A High-Performance Fluorescence Immunoassay Based on the Relaxation of Quenching, Exemplified by Detection of Cardiac Troponin I

  2016cites this paper
• A New Molecularly Imprinted Polymer (MIP)‐based Electrochemical Sensor for Monitoring Cardiac Troponin I (cTnI) in the Serum

  2016cites this paper
• Nanobiosensor Technology for Cardiovascular Diseases

  2016cites this paper
• An historical approach to the diagnostic biomarkers of acute coronary syndrome.

  2016cites this paper
• Temperature‐Dependent Postmortem Changes in Human Cardiac Troponin‐T (cTnT): An Approach in Estimation of Time Since Death

  2016cites this paper
• Biochemical Markers of Myocardial Damage

  2016cites this paper
• High-sensitivity cardiac troponin testing for primary care: analytical assay considerations required before widespread implementation.

  2016cites this paper
• High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

  2016cites this paper
• Graphene quantum dots FRET based sensor for early detection of heart attack in human.

  2016cites this paper
• Diagnostics on acute myocardial infarction: Cardiac troponin biomarkers.

  2015cites this paper
• The effect of elapsed time on the cardiac Troponin-T (cTnT) proteolysis in case of death due to burn: A study to evaluate the potential forensic use of cTnT to determine the postmortem interval.

  2015cites this paper
• Diagnostic efficacy of cardiac troponin in post?mortem examination of acute myocardial infarction

  2015cites this paper
• Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers

  2015cites this paper
• Initial Evaluation of the Meritas Troponin I test for Measurement of Equine Cardiac Troponin I

  2015cites this paper
• Electrochemical aptasensor of cardiac troponin I for the early diagnosis of acute myocardial infarction.

  2015cites this paper
• Comparison of M yoglobin , Creatine Kinase-MB , and Cardiac Troponin I for Diagnosis of Acute Myocardial Infarction *

  2015cites this paper
• The effect of elapsed time on cardiac troponin-T (cTnT) degradation and its relation to postmortem interval in cases of electrocution.

  2015cites this paper
• KUZU VE OĞLAKLARDAKİ MİYOKARDİYAL HASARIN BELİRLENMESİNDE KARDİYAK TROPONİNLERİN ETKİNLİĞİNİN ARAŞTIRILMASI

  2014cites this paper
• Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells.

  2014cites this paper
• Cardiac Troponin Specific Autoantibodies: Analytical Tools for Exploring Their Impact on Cardiac Troponin I Testing

  2014cites this paper
• The Influence of Age on Serum Concentrations of Cardiac Troponin I

  2014cites this paper
• The most sensitive double-marker method of cardiac isoenzymes of creatinine kinase, troponin I, and myoglobin in different time periods for diagnosing acute myocardial infarction

  2014cites this paper
• Graphene-gated biochip for the detection of cardiac marker Troponin I.

  2014cites this paper
• Electrochemiluminescence immunosensor using poly(l-histidine)-protected glucose dehydrogenase on Pt/Au bimetallic nanoparticles to generate an in situ co-reactant.

  2014cites this paper
• Circulating MicroRNAs as Novel Biomarkers for the Early Diagnosis of Acute Coronary Syndrome

  2013cites this paper
• Label-free electrochemiluminescence immunosensor for cardiac troponin I using luminol functionalized gold nanoparticles as a sensing platform.

  2013cites this paper
• Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).

  2013cites this paper
• Cardiac Operations Patterns and Potential Value of Cardiac Troponin I Elevations After Pediatric

  2013cites this paper
• Assessment of Leptin Hormone and Some Cardiac Biomarkers among Congestive Heart Failure patients' in Gaza Governorate - Palestine

  2013cites this paper
• Assessment of patients with symptoms suggestive of acute coronary syndrome : the use of high sensitive cardiac troponin T and a risk score

  2013cites this paper
• Prognostic Risk Stratification of Acute Coronary Syndrome Role of Highly Sensitive C-Reactive Protein

  2013cites this paper
• Quenching effect on gold nano-patterned cardiac troponin I chip by total internal reflection fluorescence microscopy.

  2013cites this paper
• Challenges in Routine Clinical Chemistry Analysis: Proteins and Enzymes

  2013cites this paper
• Update on the use of cardiac markers in the diagnosis of acute coronary syndrome

  2013cites this paper
• Unstable Angina and Non-ST Segment Elevation Myocardial Infarction (Acute Coronary Syndromes)

  2013cites this paper
• Diagnostic Value of Cardiac Troponin I in Postmortem Diagnosis of Myocardial Infarction

  2013cites this paper
• Cardiac Troponin I Level in STEMI and Clinical Correlation with Left Ventricular Dysfunction in Indian Population

  2013influential citation
• Developing Electrochemical Biosensors for Point-of-care Diagnostics of Cardiovascular Biomarkers

  2013cites this paper
• Evaluation eines ultrasensitiven Troponin-I Assays als Screening-Test und zur Unterscheidung verschiedener Schweregrade der felinen hypertrophen Kardiomyopathie

  2012cites this paper
• Antibodies in Nanomedicine and Microimaging Methods

  2012cites this paper
• Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation.

  2012cites this paper
• Reflections on the evolution of cardiac biomarkers.

  2012cites this paper
• Cardiac Troponins I and T: Molecular Markers for Early Diagnosis, Prognosis, and Accurate Triaging of Patients with Acute Myocardial Infarction

  2012cites this paper
• Using repeated measures of blood biomarkers and physical biomeasures to define changes in volume status in patients with decompensated heart failure, normal volunteers and patients with stable left ventricular systolic dysfunction

  2012cites this paper